Parkinson's disease occurs when brain cells that produce an important hormone called dopamine begin to die off or become ...

People with Parkinson’s often stay silent about their diagnosis. Here’s what drives that silence and why understanding it ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

His work blended classic design with a loose ’60s-style energy, giving publications like Rolling Stone an identity that ...

For Oak Cliff native Katherine Craft, the new audio comedy series Shaky is personal. The writer-director’s nine-episode ...

Parkinson's disease affects approximately 10 million people worldwide. It typically begins asymmetrically, initially ...

Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

Ambroxol increased enzyme levels in Parkinson’s dementia patients, but showed no cognitive benefit in a year-long trial.

Researchers in Chicago believe they’ve found a virus that could be a trigger for Parkinson’s disease. Parkinson’s impacts ...

Groundbreaking new research released from Northwestern Medicine discovered that a usually harmless virus in the blood, may be triggering Parkinson's disease.